Results for PARP1 inhibition in a recentNSCLC trial for patients with homologous repair deficiency were inconclusive;52 however, another trial is ongoing (NCT03976362). This evidence concerns the gene PARP1 and hyperinsulinemic hypoglycemia, familial, 4.